Home > Insider Trading > Filing (0001209191-23-003073)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879407	Arrowhead Pharmaceuticals Inc.	ARWR	Pharmaceutical Preparations (2834)	460408024

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1553338	D. William Waddill	177 E. Colorado Blvd Suite 700 Pasadena CA 91105		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-01-09	3,200	$30.00	28,950	No	4	S	Direct
Common Stock	Acquisiton	2023-01-10	7,867	$0.00	36,817	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Acquisiton	2023-01-10	4,593	$0.00	4,593	$33.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,593	2024-01-10	2033-01-10	No	4	A	Direct

Footnotes

The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units. The shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Represents shares underlying restricted stock units, which will vest in one installment on the first anniversary of the grant date.
Represents options, which will vest in one installment on the first anniversary of the grant date.